UK markets closed

Ocuphire Pharma, Inc. (R3X1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.8180+0.1220 (+7.19%)
At close: 09:55PM CEST
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts4444
Avg. Estimate-0.34-0.31-4.19-1.42
Low estimate-0.41-0.41-4.69-1.59
High estimate-0.26-0.19-3.88-1.3
Year ago EPS-1.96-4.18-5.28-4.19
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts3333
Avg. EstimateN/AN/A30kN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/A100kN/A
Year ago salesN/AN/AN/A30k
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/09/201931/12/202031/03/202130/06/2021
Est. EPS-2.16-0.42-0.71-0.36
Actual EPS-1.96-4.18-3.57-0.52
Difference0.2-3.76-2.86-0.16
Surprise %9.30%-895.20%-402.80%-44.40%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.34-0.31-4.19-1.42
7 days ago-0.34-0.31-4.19-1.42
30 days ago-0.34-0.31-4.19-1.42
60 days ago-0.34-0.36-1.55-1.34
90 days ago-0.35-0.35-1.59-1.35
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesR3X1.FIndustrySector(s)S&P 500
Current qtr.82.70%N/AN/AN/A
Next qtr.92.60%N/AN/AN/A
Current year20.60%N/AN/AN/A
Next year66.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A